Aliso Viejo, CA – December 15, 2016 – Cianna Medical announced today that is has been selected as a finalist in this year’s Fierce Innovation Awards: Life Sciences Edition, an awards program from the publisher of FierceBiotech and FiercePharma. Cianna Medical was recognized as a finalist in the category of Technology Innovation.
Cianna Medical was selected as a finalist for its innovative product, SAVI SCOUT® Radar Localization system, a zero-radiation and wire-free solution for breast tumor localization. SCOUT is designed to aid surgeons in locating target tissue during a lumpectomy or surgical biopsy procedure. This product represents the first time radar is successfully used in human tissue.
Finalists’ applications were reviewed by an exclusive panel of executives from Medidata, PwC, PPD, Amgen and more. All applications were evaluated based on the following criteria: effectiveness, technical innovation, competitive advantage, financial impact and true innovation. Winners will be announced on Wednesday, December 21 at 2:00 P.M. during a Live Awards Webcast. Register to attend here.
FierceMarkets, a division of Questex, LLC, is a leader in B2B e-media, providing information and marketing services in the telecommunications, life sciences, healthcare, IT, energy, government, finance, and retail industries through its portfolio of email newsletters, websites, webinars and live events. Every business day, FierceMarkets’ wide array of digital publications reaches more than 2 million executives in more than 100 countries.
About SAVI SCOUT®
The FDA-cleared SCOUT system features micro-impulse radar to detect a reflector that is placed at the tumor site up to seven days before a lumpectomy or surgical biopsy. During the procedure, the surgeon scans the breast using the SCOUT handpiece, which emits infrared light and a micro-impulse signal to detect the location of the reflector. Real-time audible and visual indicators assist the surgeon in accurately locating the reflector, along with the target tissue. This higher level of localization precision allows the surgeon to plan a surgical approach that may result in a better cosmetic outcome.
About Cianna Medical, Inc.
Cianna Medical develops, manufactures and markets innovative medical technologies that reduce costs, improve quality, and reduce the burden breast cancer treatment places on women and their families. Its SAVI® technologies are FDA-cleared and address unmet needs in the delivery of radiation therapy, tumor localization and surgical guidance.
For more information, call 866-920-9444 or visit www.ciannamedical.com